the last week in june, page-27

eventit i believe most thought that news would have flowed in june. The TJAB announcement said executed by july 1 or earlier but if you go to the last update on funding secured ANP stated that it would be in July not july 1 so looks like they made room for it to be slightly later in July.

"In relation to its other pipeline drugs, ANP expects to execute a Strategic Alliance and Joint Venture
Agreement with Tianjin International Joint Academy of Biotechnology and Medicine (TJAB) by July
2012 which would see ATL1102 move back into development for multiple sclerosis, as well as for the
new stem cell mobilization and asthma indications."

Also they stated in the same announcement that they will be in a position to announce material outcomes of due diligence by mid year and Afandin update. Most would think mid year being end June. Well surely mid year though would have a window of anywhere in June to July.

"The Company also advises that previously reported licensing due diligence activities being conducted
by an international pharmaceutical company in relation to ATL1103 are progressing and ANP
anticipates being in a position to report on any material outcomes from this process before the
middle of this year."

"By mid-year, ANP also expects to advise of the
status of its Option to License Agreement for ATL1101 for cancer with Afandin Pty Ltd."

June being a bad month for news with tax selling id expect a big July with news on all these fronts.